|
Asthma Prescription Numbers Slow Down
Genetic Engineering News The asthma prescription market is slowing as the leading drugs lose patent protection. But leading market researchers BCC and GBI Research each predict moderate growth until at least 2017, thanks to new market entrants and a disease prevalence that … |
View full post on asthma – Google News